Search Result

Results for "

VEGF-B

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Interleukin Related (1) mRNA (1) Small Interfering RNA (siRNA) (3) TNF Receptor (1) VEGFR (6)
By Research Areas:	Cancer (4) Cardiovascular Disease (4) Inflammation/Immunology (2)
Oligonucleotides:	Rat Pre-designed siRNA Sets (1) mRNA (1) Mouse Pre-designed siRNA Sets (1) Human Pre-designed siRNA Sets (1) siRNAs (3)

Inhibitors & Agonists

Peptides

Inhibitory Antibodies

Recombinant Proteins

Antibodies

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-P990540

*Anti-VEGFB* Antibody (CSL346)** CSL346; Reflocibart	VEGFR	Inflammation/Immunology
Anti-VEGFB Antibody (CSL346) is a CHO-expressed human antibody that targets *VEGFB. Anti-VEGFB* Antibody (CSL346) contains huIgG4SP heavy chain and huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for Anti-VEGFB Antibody (CSL346) can be referenced as Human IgG4 kappa, Isotype Control (HY-P99003).

HY-P99830

Conbercept KH902	VEGFR TNF Receptor Interleukin Related	Cardiovascular Disease Inflammation/Immunology Cancer
Conbercept (KH902) is a recombinant fusion protein composed of VEGFR-1 (second domain) and VEGFR-2 (third and fourth domains) regions fused to human IgG1 Fc. Conbercept is a *VEGF* inhibitor (IC₅₀ = 8.8 pM) and is a soluble receptor decoy that blocks all isoforms of *VEGF-A* (K_d = 0.5 pM), *VEGF-B* (K_d = 8 pM), *VEGF-C, and PlGF* (K_d = 5 pM). Conbercept has anti-inflammatory effects, can lower the levels of *VEGF, TNF-α* and IL-6, and reduce the infiltration of inflammatory cells. Conbercept decreases tumor growth in several oncology studies. Conbercept can be used for various eye diseases such as polypoidal choroidal vasculopathy (PCV), diabetic macular edema (DME) and pathologic myopia choroidal neovascularization (pmCNV) .

HY-P10831

GNQWFI	VEGFR	Cardiovascular Disease Cancer
GNQWFI, an anti-Flt1 peptide, is a VEGFR1-specific antagonist. GNQWFI blocks the interaction of VEGFR1 with various VEGFR1 ligands, such as VEGFA, VEGFB, and placental growth factor (PIGF) and inhibits VEGF-induced endothelial cell migration and tube formation. GNQWFI is promising for research of cancer, asthma, and other ocular diseases .

HY-P10550

VGB4	VEGFR	Cancer
VGB4 is a *VEGF-A* and *VEGF-B* antagonist peptide that duplicates two binding domains of *VEGF-B* (loop 1 and loop3) and are linked together by the receptor-binding domain of *VEGF-A* (loop3). VGB4 has significant anti-angiogenic and anti-tumor activities and can regulate tumor growth and metastasis through multiple mechanisms. VGB4 could be used in anti-tumor research .

HY-RS18083

Vegfb Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Vegfb Mouse Pre-designed siRNA Set A contains three designed siRNAs for Vegfb gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Vegfb Mouse Pre-designed siRNA Set A Vegfb Mouse Pre-designed siRNA Set A

HY-174509

*Human VEGFB* mRNA**	mRNA	Cancer
Human VEGFB mRNA encodes the human vascular endothelial growth factor B (VEGFB) protein, a member of the platelet-derived growth factor (PDGF)/ vascular endothelial growth factor (VEGF) family. VEGFB is a growth factor for endothelial cells.

HY-RS15636

VEGFB Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
VEGFB Human Pre-designed siRNA Set A contains three designed siRNAs for VEGFB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VEGFB Human Pre-designed siRNA Set A VEGFB Human Pre-designed siRNA Set A

HY-RS24557

Vegfb Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Vegfb Rat Pre-designed siRNA Set A contains three designed siRNAs for Vegfb gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Vegfb Rat Pre-designed siRNA Set A Vegfb Rat Pre-designed siRNA Set A

HY-P11775A

Peptide HRH acetate	VEGFR	Cardiovascular Disease
Peptide HRH acetate is a polypeptide that specifically binds to *VEGF* receptors. Peptide HRH acetate inhibits *VEGF*-stimulated endothelial cell proliferation. Peptide HRH acetate inhibits angiogenesis and suppresses corneal neovascularization. Peptide HRH acetate can be used in anti-angiogenesis related studies .

HY-P11775

Peptide HRH	VEGFR	Cardiovascular Disease
Peptide HRH is a polypeptide that specifically binds to *VEGF* receptors. Peptide HRH inhibits *VEGF*-stimulated endothelial cell proliferation. Peptide HRH inhibits angiogenesis and suppresses corneal neovascularization. Peptide HRH can be used in anti-angiogenesis related studies .

Cat. No.	Product Name	Target	Research Area

HY-P10831

GNQWFI	VEGFR	Cardiovascular Disease Cancer
GNQWFI, an anti-Flt1 peptide, is a VEGFR1-specific antagonist. GNQWFI blocks the interaction of VEGFR1 with various VEGFR1 ligands, such as VEGFA, VEGFB, and placental growth factor (PIGF) and inhibits VEGF-induced endothelial cell migration and tube formation. GNQWFI is promising for research of cancer, asthma, and other ocular diseases .

HY-P10550

VGB4	VEGFR	Cancer
VGB4 is a *VEGF-A* and *VEGF-B* antagonist peptide that duplicates two binding domains of *VEGF-B* (loop 1 and loop3) and are linked together by the receptor-binding domain of *VEGF-A* (loop3). VGB4 has significant anti-angiogenic and anti-tumor activities and can regulate tumor growth and metastasis through multiple mechanisms. VGB4 could be used in anti-tumor research .

HY-P11775A

Peptide HRH acetate	VEGFR	Cardiovascular Disease
Peptide HRH acetate is a polypeptide that specifically binds to *VEGF* receptors. Peptide HRH acetate inhibits *VEGF*-stimulated endothelial cell proliferation. Peptide HRH acetate inhibits angiogenesis and suppresses corneal neovascularization. Peptide HRH acetate can be used in anti-angiogenesis related studies .

HY-P11775

Peptide HRH	VEGFR	Cardiovascular Disease
Peptide HRH is a polypeptide that specifically binds to *VEGF* receptors. Peptide HRH inhibits *VEGF*-stimulated endothelial cell proliferation. Peptide HRH inhibits angiogenesis and suppresses corneal neovascularization. Peptide HRH can be used in anti-angiogenesis related studies .

Cat. No.	Product Name	Target	Research Area	Image

HY-P990540

*Anti-VEGFB* Antibody (CSL346)** CSL346; Reflocibart	VEGFR	Inflammation/Immunology
Anti-VEGFB Antibody (CSL346) is a CHO-expressed human antibody that targets *VEGFB. Anti-VEGFB* Antibody (CSL346) contains huIgG4SP heavy chain and huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for Anti-VEGFB Antibody (CSL346) can be referenced as Human IgG4 kappa, Isotype Control (HY-P99003).

HY-P99830

Conbercept KH902	VEGFR TNF Receptor Interleukin Related	Cardiovascular Disease Inflammation/Immunology Cancer
Conbercept (KH902) is a recombinant fusion protein composed of VEGFR-1 (second domain) and VEGFR-2 (third and fourth domains) regions fused to human IgG1 Fc. Conbercept is a *VEGF* inhibitor (IC₅₀ = 8.8 pM) and is a soluble receptor decoy that blocks all isoforms of *VEGF-A* (K_d = 0.5 pM), *VEGF-B* (K_d = 8 pM), *VEGF-C, and PlGF* (K_d = 5 pM). Conbercept has anti-inflammatory effects, can lower the levels of *VEGF, TNF-α* and IL-6, and reduce the infiltration of inflammatory cells. Conbercept decreases tumor growth in several oncology studies. Conbercept can be used for various eye diseases such as polypoidal choroidal vasculopathy (PCV), diabetic macular edema (DME) and pathologic myopia choroidal neovascularization (pmCNV) .

Recombinant Proteins Recommended:

VEGF-B

Cat. No.	Compare	Product Name	Species	Source	Image

HY-P72431

	VEGF-B Protein, Human (HEK293, Fc) 2 Publications Verification Vascular endothelial growth factor B; VEGF-B; VRF	Human	HEK293
	VEGF-B protein is an endothelial cell-specific growth factor with VEGF-B167 and VEGF-B186 isoforms and has a unique binding ability to heparin and Neuropilin-1. VEGF-B Protein, Human (HEK293, Fc) is the recombinant human-derived VEGF-B protein, expressed by HEK293 , with N-hFc labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P82882

	VEGFB Antibody (YA2627) VEGFB; VRF; Vascular endothelial growth factor B; VEGF-B; VEGF-related factor; VRF	WB	Human, Mouse
	VEGFB Antibody (YA2627) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to VEGFB.